Afuco™ Anti-Human Integrin αvβ6 ADCC Therapeutic Antibody (264RAD), ADCC Enhanced
Anti-Integrin αvβ6 ADCC Enhanced Antibody (264RAD) is an ADCC enhanced antibody produced by our Afuco™ platform. 264RAD is a human therapeutic antibody, which binds and inhibits αvβ6 integrin function. 264RAD cross-reacts with human, mouse and cynomolgus monkey αvβ6, and inhibits binding to all ligands including the latency-associated peptide of TGF-β. 264RAD is a potent inhibitor of αvβ6 integrin, with some activity against αvβ8 integrin, that reduces both tumour growth and metastasis.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-431CL |
| Pricing | Inquiry |
| Host | Human |
| Target | Integrin αvβ6 |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Storage | Store at -20°C for long-term storage. Store at 4°C for up to one month. Avoid freeze/thaw cycles. |